Wockhardt Becomes First Indian Drug Maker to Receive EMR
Nadoxin is a treatment against a wide spectrum of topical bacterial infections. A post-marketing surveillance study conducted on 696 patients across the country has established a 99% success rate for Nadoxin, the company said.
Wockhardt is only the second pharmaceutical company to receive an EMR after Novartis secured rights for its...
To view the full article, register now.